ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,818.29
      1.60%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Rxi Pharmaceuticals Corp. (MM) (RXII)

      7. Rxi Pharmaceuticals Corp. (MM) (RXII) News

      RXII

      RXI Pharmaceuticals Corporation (RXII)

      Rxi Pharmaceuticals Corp. (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RXII
      DateTimeSourceHeadlineSymbolCompany
      08/24/20185:04PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/21/20189:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/17/20185:02PMEdgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (d/a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/15/20189:25AMPR Newswire (US)RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/14/20189:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/14/20189:15AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/14/20189:15AMPR Newswire (US)RXi Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Corporate HighlightsNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/07/20187:15AMPR Newswire (US)RXi Pharmaceuticals to Webcast Second Quarter 2018 Financial Results on Tuesday, August 14, 2018NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/02/20189:25AMPR Newswire (US)RXi Pharmaceuticals Granted Patents for sd-rxRNA Technology Strengthening Intellectual Property Estate in Europe and JapanNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/01/20189:25AMPR Newswire (US)RXi Pharmaceuticals Announces Positive Results From Phase 1/2 Trial With RXI-109 For Retinal ScarringNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      06/28/20188:00AMBusiness WireBioAxone BioSciences Awarded $1.1 Million Phase 2 SBIR Funding for Continued Development of sd-rxRNA Drug Candidate for the T...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      06/28/20188:00AMPR Newswire (US)BioAxone BioSciences Awarded $1.1 Million Phase 2 SBIR Funding for Continued Development of sd-rxRNA Drug Candidate for the T...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      06/08/20185:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      06/01/20185:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      06/01/20186:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/18/201811:58AMPR Newswire (US)RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with Samcyprone™ for the Treatment of Common WartsNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/11/20187:05AMPR Newswire (US)RXi Pharmaceuticals Enters into Material Transfer Agreement with Iovance Biotherapeutics to Study its Self-Delivering RNAi Te...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/10/20187:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/10/20187:09AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/10/20187:05AMPR Newswire (US)RXi Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Corporate HighlightsNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/09/20185:33PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/08/20182:20PMPR Newswire (US)RXi Pharmaceuticals Bolsters Strength of Dermatology Intellectual Property Estate Following Granting of Patent From USPTONASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      05/01/20187:05AMPR Newswire (US)RXi Pharmaceuticals Announces Presentation at the 2018 New York Oncology Investment ConferenceNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/26/20185:03PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/26/20185:00PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/24/20187:05AMPR Newswire (US)RXi Pharmaceuticals to Webcast First Quarter 2018 Financial Results on Thursday, May 10, 2018NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/18/20185:21PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/18/20184:50PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/16/201811:25AMPR Newswire (US)RXi Pharmaceuticals Announces Publication in Molecular Therapy on Self-Delivering RNAi (sd-rxRNA®) Targeting PD-1 in Adoptiv...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/13/20185:18PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
       Showing the most relevant articles for your search:NASDAQ:RXII

      Your Recent History

      BOV
      F1RA34Q
      Franklin Resources
      Delayed Upgrade Clock